FORADIL AEROLIZER

Compare FORADIL AEROLIZER  to:
Compare
Compare

Generic Name for FORADIL AEROLIZER

Formoterol fumarate 12 micrograms/inh; dry pwd in caps for inhalation; with inhaler device.

Legal Classification:

Rx

Pharmacological Class for FORADIL AEROLIZER

Long-acting β2-agonist.

Manufacturer of FORADIL AEROLIZER

Merck & Co., Inc.

Indications for FORADIL AEROLIZER

As an adjunct (see literature): For the maintenance treatment of asthma and in the prevention of bronchospasm in reversible obstructive airway disease (including nocturnal asthma). Maintenance treatment of COPD-associated bronchospasm. Prevention of exercise-induced bronchospasm (EIB).

Adults and Children:

<5 years: not recommended. ≥5 years: 1 inh (12 micrograms) every 12 hours. Prevention of EIB: 1 inh at least 15 minutes before exercise (do not use additional doses for EIB if already using regular dosing for asthma).

Contraindications for FORADIL AEROLIZER

Not for treatment of acute attacks or when occasional use of short-acting drugs suffices. Do not initiate in significantly worsening or acutely deteriorating asthma. Formoterol is not a substitute for steroids. Do not exceed recommended dose.

Warnings/Precautions for FORADIL AEROLIZER

Not for use with other long-acting β2-agonists. Cardiovascular disease (esp. hypertension, coronary insufficiency, arrhythmias). Convulsive disorders. Thyrotoxicosis. Hyperresponsiveness to sympathomimetics. Evaluate response before altering steroid doses (may still need an antiinflammatory). Prescribe a short-acting, inhaled β2-agonist for acute symptoms; monitor for increased need. Do not use with spacers. Labor & delivery. Pregnancy (Cat.C). Nursing mothers.

Interactions for FORADIL AEROLIZER

Avoid MAOIs, tricyclic antidepressants, drugs that prolong QTc. Hypokalemia potentiated by xanthines, steroids, or diuretics. Antagonized by β-blockers.

Adverse Reactions for FORADIL AEROLIZER

Infection, tremor (skeletal muscle), dizziness, insomnia, dysphonia, tonsillitis, paradoxical bronchospasm, β2-agonist effects (eg, hypo- or hypertension, angina, tachycardia, arrhythmias, nervousness, hypokalemia, hyperglycemia, metabolic acidosis); rarely: serious asthma episode, asthma-related death.

How is FORADIL AEROLIZER supplied?

Caps—12, 60

Related Disease:

Asthma~antiasthmatics
Bronchospasm~bronchodilators
COPD {COPD}

Related Resources

FDA warns of stolen Advair Diskus product

July 19, 2010

The FDA has warned healthcare professionals and consumers not to use certain Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhalers stolen from a distribution warehouse in 2009 which have been found recently in some pharmacies.

Glassia approved for treating alpha 1 antitrypsin deficiency

July 06, 2010

Kamada announced that the FDA has approved Glassia (alpha1-proteinase inhibitor liquid) for chronic augmentation and maintenance therapy in adults with emphysema due to congenital deficiency of alpha1-proteinase inhibitor (AATD).

Dulera approved for the treatment of asthma

June 24, 2010

Merck announced that the FDA has approved Dulera (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients ≥12 years of age.

Phase 2b study of Aerovant for the treatment of eosinophilic asthma

June 08, 2010

Aerovance Inc. announced top-line results from its Phase 2b trial demonstrating that Aerovant (pitrakinra) is effective in a pre-defined subset of patients with eosinophilic asthma.

AeroChamber Plus Flow-Vu anti-static valved holding chamber available

June 04, 2010

Forest Pharmaceuticals and Lupin Pharmaceuticals have made available the AeroChamber Plus Flow-Vu anti-static valved holding chamber for use with metered dose inhalers (MDI).

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions